Live Oak Investment Partners Pfizer Inc Transaction History

Live Oak Investment Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $16,043 - $20,839	-614 Reduced 4.55%	12,866 $370,000
Q3 2023 Oct 31, 2023	BUY	$32.09 - $37.51 $2,085 - $2,438	65 Added 0.48%	13,480 $447,000
Q2 2023 Jul 13, 2023	BUY	$36.12 - $41.79 $10,330 - $11,951	286 Added 2.18%	13,415 $492,000
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $62,984 - $81,996	1,599 Added 13.87%	13,129 $535,000
Q4 2022 Feb 15, 2023	BUY	$41.75 - $54.5 $481,377 - $628,385	11,530 New	11,530 $591,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Live Oak Investment Partners, based on Form 13F filings with the SEC.

Stay updated on Live Oak Investment Partners with notifications on news.